Biotechnology Stock

Ligand Pharmaceuticals Inc.

Ligand Pharmaceuticals Inc. is an early-stage biotechnology company, focused on discovering and developing new drugs that address critical unmet medical needs in the areas of thrombocytopenia, cancer, hepatitis C, hormone-related diseases, osteoporosis and inflammatory diseases. The company strives to develop drugs that are more effective and/or safer than existing therapies, that are more ... more

Peregrine Pharmaceuticals, Inc

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of novel therapeutics for cancer and viral diseases. It develops a portfolio of clinical and preclinical stage monoclonal antibody-based targeted therapeutics, including bavituximab that is in a multi center Phase I clinical trial for the treatment of solid cancers, as ... more

Ariad Pharmaceuticals

ARIAD Pharmaceuticals, Inc. engages in the discovery and development of medicines for the treatment of cancer by regulating cell signaling with small molecules in the United States. Its lead cancer product candidate, AP23573, is an mTOR inhibitor for the treatment of solid tumors, including sarcomas, hormone refractory prostate cancer, and endometrial cancer. AP23573 is in multiple Phase II ... more

Chelsea Therapeutics International Ltd

We are a development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases. Our strategy is to develop technologies that address important unmet medical needs or offer improved, cost-effective alternatives to current methods of treatment. Specifically, we are developing prescription products for multiple ... more

Generex Biotechnology Corp.

Generex Biotechnology Corporation engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. The companyâ€™s primary product, Oral-lyn is an insulin spray formulation used for the ... more

Supergen, Inc

SuperGen, Inc., a pharmaceutical company, engages in the discovery, acquisition, development, and commercialization of therapies for solid tumors, hematological malignancies, and blood disorders. It offers Dacogen, a pyrimidine analog that decreases the amount of methylation at certain DNA sites; Orathecin capsules, a second-generation topoisomerase I inhibitor, which causes single-strand ... more

Zymogenetics, Inc

ZymoGenetics, Inc. engages in the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases in the areas of hemostasis, inflammatory and autoimmune diseases, cancer, and viral infections. Its preclinical stage internal products include IL-31, for the treatment of atopic dermatitis and inflammatory diseases. The company's phase II ... more

Genta Incorporated

Genta Incorporatedis a biopharmaceutical company engaged in pharmaceutical (drug) research and development, its sole reportable segment. The Company is dedicated to the identification, development and commercialization of novel drugs for the treatment of cancer and related diseases.

Nexmed, Inc

NexMed, Inc. was incorporated in Nevada in 1987. The Company has historically focused its efforts on drug development using its patented drug delivery technology known as NexACT®. Following the acquisition of Bio-Quant, the Company operates in two segments - designing and developing pharmaceutical products and providing pre-clinical CRO services through its subsidiary, Bio-Quant. The ... more

Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company, incorporated in the state of Delaware, focused on developing and commercializing human embryonic and adult stem cell technology in the emerging fields of regenerative medicine. Principal activities to date have included obtaining financing, securing operating facilities, and conducting research and development. The Company has no ... more

Arrowhead Research Corp.

Arrowhead Research Corporation is a development stage nanotechnology holding company that forms, acquires and operates subsidiaries commercializing innovative nanotechnologies. By working closely with leading scientists and universities, Arrowhead identifies advances in nanotechnology and matches them with product development opportunities in high-growth markets. The Company is currently ... more

Immunomedics, Inc

Immunomedics, Inc. is a biopharmaceutical company, focused on the development of monoclonal antibody-based products for the treatment of cancer, autoimmune and other serious diseases. The compnay develops technologies, allowing to create humanized antibodies, that can be used either alone, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create targeted ... more

Xechem Intl, Inc

Xechem International, Inc. is a holding company which owns the capital stock of Xechem, Inc., a development stage company engaged in the research, development and production of medicines made from natural sources. The company currently operates in the United States, India, the People's Republic of China, and Nigeria. more

Pfizer, Inc.

Pfizer Inc. (which may be referred to as Pfizer, the Company, we, us or our) is a research-based, global pharmaceutical company. We discover, develop, manufacture and market leading prescription medicines for humans and animals. more

Axia Group, Inc.

We are currently seeking to identify clients that will need business consulting, corporate administration, capital structuring, merger and acquisition, and financial planning services, but we will not provide capital financing, underwriting, or other broker-dealer services. We are also looking for potential acquisition targets. Our management will review and evaluate business ventures for ... more

1 2 3 4 5 6 7 next total items: 404

Feedburner

Categories

Biotechnology Stock